[Angiogenesis in ophthalmology. A theme with a future].
Joussen
A M
AM
Kirchhof
B
B
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D020256:Choroidal Neovascularization / Q000473:pathology / Q000503:physiopathology; D016510:Corneal Neovascularization / Q000473:pathology / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000473:pathology / Q000503:physiopathology; D016228:Endothelial Growth Factors / Q000037:antagonists & inhibitors / Q000502:physiology; D005128:Eye Diseases / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D007231:Infant, Newborn; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology; D008222:Lymphokines / Q000037:antagonists & inhibitors / Q000502:physiology; D008268:Macular Degeneration / Q000150:complications; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D009930:Organic Chemicals; D010982:Platelet-Derived Growth Factor / Q000502:physiology; D011244:Pregnadienediols / Q000627:therapeutic use; D015861:Retinal Neovascularization / Q000473:pathology / Q000503:physiopathology; D012178:Retinopathy of Prematurity / Q000473:pathology / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D009930:Organic Chemicals; D010982:Platelet-Derived Growth Factor; D011244:Pregnadienediols; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C113282:prinomastat; D008666:Metalloendopeptidases; C418047:anecortave acetate